|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
ISO |
[Beryllium results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA |
CTD |
PMID:11872642 |
|
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
|
|
G |
ESR1 |
estrogen receptor 1 |
increases methylation |
ISO |
Beryllium results in increased methylation of ESR1 gene |
CTD |
PMID:11872642 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
affects binding increases response to substance |
EXP |
HLA-DPB1 protein mutant form binds to Beryllium HLA-DPB1 gene polymorphism results in increased susceptibility to Beryllium; HLA-DPB1 gene SNP results in increased susceptibility to Beryllium; HLA-DPB1 protein mutant form results in increased susceptibility to Beryllium |
CTD |
PMID:11551429 PMID:15273960 PMID:17956852 |
|
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696
|
|
G |
HRAS |
HRas proto-oncogene, GTPase |
increases mutagenesis |
ISO |
Beryllium results in increased mutagenesis of HRAS gene |
CTD |
PMID:7545909 |
|
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
|
|
G |
IL1B |
interleukin 1 beta |
increases expression affects expression |
EXP |
Beryllium results in increased expression of IL1B mRNA Beryllium affects the expression of IL1B mRNA |
CTD |
PMID:8473757 PMID:8629860 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
TNF |
tumor necrosis factor |
increases response to substance increases secretion increases expression |
EXP |
TNF promoter polymorphism results in increased susceptibility to Beryllium Beryllium results in increased secretion of TNF protein Beryllium results in increased expression of TNF mRNA |
CTD |
PMID:8629860 PMID:12449171 PMID:15127972 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|